To investigate the mutational profiles of PTPRD or PTPRT in Chinese NSCLC population, a total of 1224 cases of Chinese NSCLC who have undergone 733 cancer gene-panel via next-generation sequencing (NGS) were included in this study, including 886 patients with lung adenocarcinoma and 188 patients with lung squamous cell carcinoma (Table S4). The gene discussed is PTPRD; the disease is lung adenocarcinoma.